Fly News Breaks for January 14, 2020
Jan 14, 2020 | 06:54 EDT
Benchmark analyst Bill Sutherland noted that Surgery Partners confirmed at an industry conference yesterday that its Q4 was at least in line with consensus and that 2020 would be another year of double-digit AEBITDA growth. Sutherland raised his price target on the shares to $19 from $13 as he expects same-store revenue growth can remain at the top end of management's 4%-6% guidance range and sees the current use of cash helping the company's sustainable growth and margins. He keeps a Buy rating on Surgery Partners shares.
News For SGRY From the Last 2 Days
There are no results for your query SGRY